Drug Delivery Market Share Report | Global Outlook 2023-2028

report image

Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)

Publication Month: May 2023 | Report Code: TIPRE00029924 | No. of Pages: 314 | Category: Pharmaceuticals | Status: Published

[Research Report] The drug delivery market size is expected to grow from US$ 20,99,856.7 million in 2022 to US$ 32,54,594.2 million by 2028; it is estimated to record a CAGR of 7.7% from 2023 to 2028.

The drug delivery market is segmented based on route of administration, distribution channel, end user, and geography. The report offers insights and in-depth market analysis, emphasizing parameters such as drivers, trends, opportunities, and competitive landscape analysis of leading market players across various regions. It also includes analyses of the impact of the COVID-19 pandemic across major regions.

Strategic Insights

Report Coverage - Drug Delivery Market
Report CoverageDetails
Market Size Value inUS$ 20,99,856.7 million in 2022
Market Size Value byUS$ 32,54,594.2 million by 2028
Growth rateCAGR of 7.7% from 2023 to 2028
Forecast Period2023-2028
Base Year2022
No. of Pages314
No. of Tables219
No. of Charts & Figures93
Historical data availableYes
Segments coveredRoute of Administration, Distribution Channel, and End User
Free Sample Copy Available

Market Insights

Growing Demand for Noninvasive Drug Delivery Systems Drives Drug Delivery Market

Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery market.

Route of Administration-Based Insights

Based on the route of administration, the drug delivery market is segmented into oral drug delivery, injectable drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. In 2022, the injectable drug delivery segment held the largest share of the drug delivery market. However, the topical drug delivery segment is anticipated to register the highest CAGR during the forecast period. Injectable drug delivery is considered one of the effective routes of drug administration due to the speed and effectiveness of delivery to the target site and improved patient experience. The injections help administer drugs, vaccines, or any other therapeutic agents into the body. The drug delivery technique via a route other than the digestive tract is termed parenteral. The parenteral route of administration includes intramuscular, subcutaneous, and intravenous. The development of needle-free injectors has improved insulin drug delivery by reducing the risk of needlestick injuries in diabetic patients.

Increasing usage of injections in complex drug delivery procedures due to advancements in injectable drug delivery systems and the introduction of next-generation injectable devices with superior functional capabilities enhance the global drug delivery market growth for the injectable drug delivery segment.

Drug Delivery Market, by Route of Administration– 2022–2028

Get more information on this report :

Distribution Channel-Based Insights

Based on distribution channel, the drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2022 and is expected to record the highest CAGR during the forecast period.

End User-Based Insights

Based on end user, the drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment accounted for the largest market share in 2022 and is projected to record the highest CAGR during the forecast period.

The drug delivery market players adopt organic strategies such as product launch and expansion to expand their geographic footprint and product portfolios and meet the growing demands. Inorganic growth strategies adopted by market players allow them to expand their businesses and enhance their geographic presence. Additionally, these growth strategies help companies strengthen their clientele and enlarge their product portfolios.

  • In September 2022, Becton, Dickinson, and Company introduced a next-generation glass pre-fillable syringe (PFS) and set a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. The new BD Effivax glass pre-fillable syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.
  • In June 2022, Pfizer Inc. strengthen its commitment to United States manufacturing with a US$120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets). The investment expanded the production of active pharmaceutical ingredients (API) and registered starting materials (RSMs) used to manufacture nirmatrelvir.

Company Profiles

  • Becton Dickinson and Co             
  • Novo Nordisk AS
  • Johnson & Johnson                     
  • Boston Scientific Corp
  • Pfizer Inc.                                
  • Baxter International Inc               
  • Gerresheimer AG                       
  • Kindeva Drug Delivery LP            
  • GlaxoSmithKline Plc                    
  • Bausch Health Companies            
  • Novartis AG                              
  • Sever Pharma Solutions
  • Boehringer Ingelheim International

Frequently Asked Questions

The factors that are driving the growth of market are growth are rising incidence of chronic diseases, growing demand for noninvasive drug delivery systems, and increasing R&D expenditures in pharmaceutical companies propel the market growth.
Drug delivery are various methodologies used to inject drugs or chemicals into the body. Some of the drug delivery available in the market include, transmucosal, oral, injectable, topical, implantable, and ocular among others. Drug delivery are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.
The drug delivery market majorly consists of the players such as Pfizer Inc, Johnson & Johnson, Becton Dickinson and Co, Novo Nordisk AS, Boston Scientific Corp, Baxter International Inc, Gerresheimer AG, Kindeva Drug Delivery LP, GlaxoSmithKline Plc, Bausch Health Companies, Novartis AG, Sever Pharma Solutions, Boehringer Ingelheim International.
The drug delivery market is analyzed in the basis of route of administration, distribution channel, and end user. Based on route of administration, is segmented into oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest market share in 2022. However, topical drug delivery segment is anticipated to register the highest CAGR during the forecast period.

The List of Companies - Drug Delivery Market

  1. Becton, Dickinson and Co                
  2. Novo Nordisk AS                  
  3. Boston Scientific Corp
  4. Baxter International Inc    
  5. Gerresheimer AG                
  6. Kindeva Drug Delivery LP                 
  7. GlaxoSmithKline Plc           
  8. Bausch Health Companies               
  9. Novartis AG           
  10. Boehringer Ingelheim International
  11. Sever Pharma Solutions
  12. Pfizer Inc.               
  13. Johnson & Johnson.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount